Biofrontera Inc.
BFRI
$0.86
$0.0121.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -201.07% | 75.37% | -2,105.84% | 97.54% | -396.00% |
| Total Depreciation and Amortization | -0.90% | -29.17% | 0.97% | 0.65% | 4.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -572.00% | -95.02% | 119.65% | -222.14% | 156.28% |
| Change in Net Operating Assets | -4.63% | -96.56% | 819.30% | -86.94% | 149.89% |
| Cash from Operations | -304.82% | 15.81% | 74.41% | -41.95% | 62.50% |
| Capital Expenditure | -200.00% | -- | -100.00% | 184.21% | -733.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -187.72% | -10.94% |
| Cash from Investing | -200.00% | -- | 100.00% | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 86.17% | -15.62% | 80.38% |
| Issuance of Common Stock | -- | -- | -100.00% | -2.92% | 70.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 1,459.06% | -105.64% | -8.88% | -13.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -235.88% | 301.33% | -367.97% | -77.28% | 219.00% |